Researchers aim to stop the Bundibugyo Ebola outbreak in northeastern DRC by fast-tracking a vaccine using a proven viral-vector platform.

This funding surge aims to fast-track vaccine candidates against the deadly Ebola Bundibugyo strain.

Global health groups race to develop a Bundibugyo Ebola vaccine as cases surge in DR Congo and Uganda, with WHO backing a leading rVSV candidate.